27.80 USD
↗ 0.68 (2.51%)AT CLOSE (11:59 AM EDT)
Alumis Inc. Common Stock
ALMSNASDAQ • USD
27.78
↘ 0.02 (0.07%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
27.78
↘ 0.02 (0.07%)
Market: CLOSED
Shares of Alumis Inc. Common Stock (ALMS) are trading at $27.78. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Aug 6, 2026.
Open?$27.10
High?$28.56
Low?$27.10
Prev. Close?$27.12
Volume?653.5K
Avg. Volume?1.5M
VWAP?$27.74
Rel. Volume?0.44x
Bid / Ask
Bid?$21.62 × 100
Ask?$32.84 × 100
Spread?$11.22
Midpoint?$27.23
Valuation & Ratios
Market Cap?3.5B
Shares Out?123.4M
Float?74.5M
Float %?60.4%
P/E Ratio?N/A
P/B Ratio?6.10
EPS?-$1.86
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alumis Inc is a clinical-stage biopharmaceutical company with an initial focus on developing its two Tyrosine Kinase 2 ("TYK2") inhibitors: envudeucitinib ("envu"), an allosteric TYK2 inhibitor for the treatment of PsO and SLE; and A-005, a central nervous system ("CNS") penetrant allosteric TYK2 inhibitor, to offer the therapeutic benefit of TYK2 inhibition within the CNS for a broad range of neuroinflammatory and neurodegenerative diseases.
Themes
Address
280 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-231-6625
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-231-6625
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?27
Short Sent.?50
Piotroski F-Score?0/9Weak
Altman Z-Score?16.39Safe
Confidence?49%Low
Short InterestElevated
Short % of Float?9.08%Elevated
Short Interest?6.8M
Days to Cover?3.8
Free Float74.5M
Avg Daily Volume1.8M
Settlement Date2026-07-15
Financial Health
Current Ratio?7.51Strong
Quick Ratio?7.51Strong
Cash Ratio?0.90Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?6.10FAIR▾
Peers100
S&P30
P/S?411.52HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-7.6CHEAP▾
S&P97
EV/Sales?403.92HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-41.9%WEAK▾
S&P3
ROA?-35.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-377030000
Enterprise Value?$3.4B
Fundamentals ratios updated end of day